Clinical therapeutic effect of Linezolid for community acquired MRSA:1 case report and review of the literatures
10.3760/cma.j.issn.1008-6315.2011.07.010
- VernacularTitle:利奈唑胺治疗社区获得性耐甲氧西林金黄色葡萄球菌肺炎老年患者一例并文献复习
- Author:
Hui LI
;
Xiaoli JING
;
Xin LI
;
Xiaoxing LIAO
;
Hong ZHAN
;
Yan XING
;
Chunlin HU
;
Hongyan WEI
- Publication Type:Journal Article
- Keywords:
Pneumonia;
Community acquired infection;
Linezolid;
Staphylococcus aureus
- From:
Clinical Medicine of China
2011;27(7):697-700
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinic effect of Linezolid for community acquired methicillin resistant staphylococcus aureus (MRS A) pneumonia. Methods The clinic data of the patient- were collected from the First Affiliated Hospital of Sun Yat-Sen University, in addition, the body temperature and white blood cell counts were obtained as the index of treatment. Results It was proved that Linezolid was effective in treating community acquired MRSA pneumonia and showed well tolerance with few adverse events. Conclusion Linezolid demonstrated good clinical and antibacterial activity but very few adverse reactions in elderly patients with community acquired MRSA pneumonia.